Pitfalls in measuring cerebrospinal fluid glycine levels in infants with encephalopathy

Journal of Child Neurology

Volumn 26, Issue 6, 2011, Pages 703-706

  Aburahma, Samah ^a   Khassawneh, Mohammad ^a   Griebel, May ^b   Sharp, Gregory ^b   Gibson, James ^c  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c Specially for Children   (United States)

Author keywords

cerebrospinal fluid; encephalopathy; glycine; hyperglycinemia

Indexed keywords

GLYCINE;

ARTICLE; BLOOD LEVEL; BRAIN DISEASE; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERGLYCINEMIA; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFANT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PRIORITY JOURNAL; SEIZURE;

CHILD, PRESCHOOL; FEMALE; GLYCINE; HUMANS; HYPERGLYCINEMIA, NONKETOTIC; HYPOXIA, BRAIN; INFANT; MAGNETIC RESONANCE IMAGING; MALE; RETROSPECTIVE STUDIES;

EID: 79957627473     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810389041     Document Type: Article

References (22)

1. Saudubray JM, Nassogne MC, de Lonlay P., Touati G. Clinical approach to inherited metabolic disorders in neonates: an overview. Semin Neonatol. 2002 ; 7: 3-15. (Pubitemid 34742215)
2. Applegarth DA, Toone JR Nonketotic hyperglycinemia (glycine encephalopathy): laboratory diagnosis. Mol Genet Metab. 2001 ; 74: 139-146. (Pubitemid 32955155)
3. Korman SH, Gutman A. Pitfalls in the diagnosis of glycine encephalopathy (nonketotic hyperglycinemia). Dev Med Child Neurol. 2002 ; 44: 712-720. (Pubitemid 35230034)
4. Press GA, Barshop BA, Haas RH, et al. Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. AJNR Am J Neuroradiol. 1989 ; 10: 315-321. (Pubitemid 19082621)
5. Ilinuma K., Hayasaka K., Narisawa K., et al. Hyperaminoacidaemia and hyperammonaemia in epileptic children treated with valproic acid. Eur J Paediatr. 1988 ; 148: 267-269. (Pubitemid 19016152)
6. Tada K., Hayasaka K. Non-ketotic hyperglycinaemia: clinical and biochemical aspects. Eur J Pediatr. 1987 ; 146: 221-227. (Pubitemid 17066916)
7. Scriver CR, Rosenberg LE Amino Acid Metabolism and Its Disorders (Major Problems in Clinical Pediatrics V10). Philadelphia: WB Saunders ; 1973.
8. Perry TL, Urquhart N., MacLean J., et al. Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycine cleavage in the brain. N Engl J Med. 1975 ; 292: 1269-1273.
9. Ruppel RA, Kochanek PM, Adelson DP, et al. Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. J Pediatr. 2001 ; 138: 18-25. (Pubitemid 32097136)
10. Roldan A., Figueras-Aloy J., Deulofeu R., Jimenez R. Glycine and other neurotransmitter amino acids in cerebrospinal fluid in perinatal asphyxia and neonatal hypoxic-ischemic encephalopathy. Acta Paediatr. 1999 ; 88: 1137-1141. (Pubitemid 29489173)
11. van der Knaap MS, Wevers RA, Kure S., et al. Increased cerebrospinal fluid glycine: a biochemical marker for a leukoencephalopathy with vanishing white matter. J Child Neurol. 1999 ; 14: 728-731.
12. Jaeken J., Stibler H. A newly recognized inherited neurological disease with carbohydrate-deficient secretory glycoproteins. In: Wetterberg L., ed. Genetics of Neuropsychiatric Diseases. Wenner-Gren Center International Symposium Series. New York: Macmillan ; 1989: 69-80.
13. Maeda T., Inutsuka M., Goto K., Izumi T. Transient nonketotic hyperglycinemia in an asphyxiated patient with pyridoxinedependent seizures. Pediatr Neurol. 2000 ; 22: 225-227. (Pubitemid 30151166)
14. Luder AS, Davidson A., Gooman SI, Greene CL Transient nonketotic hyperglycinemia in neonates. J Pediatr. 1989 ; 114: 1013-1015. (Pubitemid 19151765)
15. Aliefendioglu D., Aslan AT, Coskun T., et al. Transient nonketotic hyperglycinemia: two case reports and literature review. Pediatr Neurol. 2003 ; 28: 151-155. (Pubitemid 36434165)
16. Lang TF, Parr JR, Matthews EE, et al. Practical difficulties in the diagnosis of transient non-ketotic hyperglycinaemia. Dev Med Child Neurol. 2008 ; 50: 157-159.
17. Scholl-Burgi S., Korman SH, Applegarth DA, et al. The relation of cerebrospinal fluid and plasma glycine levels in propionic acidaemia, a 'ketotic hyperglycinaemia'. J Inherit Metab Dis. 2008 ; 31: 395-398.
18. Lin FY, Gascon GG, Hyland K., et al. Transient nonketotic hyperglycinemia and defective serotonin metabolism in a child with neonatal seizures. J Child Neurol. 2006 ; 21: 900-903. (Pubitemid 46099282)
19. Boneh A., Allan S., Mendelson D., et al. Clinical, ethical and legal considerations in the treatment of newborns with non-ketotic hyperglycinaemia. Mol Genet Metab. 2008 ; 94: 143-147.
20. Hayashi Y., Ishibashi H., Hashimoto K., Nakanishi H. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors. Glia. 2006 ; 53: 660-668.
21. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987 ; 325: 529-531. (Pubitemid 17056733)
22. Lipton SA, Rosenberg PA Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994 ; 330: 613-622.